Skip to main content

Client News

Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the development of its ADC Pipeline

14th March 2024

Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment for Out-Licensing

14th March 2024

Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca

14th March 2024

Bayer and Aignostics to collaborate on next generation precision oncology

14th March 2024

Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence

12th March 2024

FYB201/Ranibizumab keeps gaining momentum with approvals and launches in the MENA region

11th March 2024

MIG Capital: MIG Capital leads €5 million Series A financing of animal healthcare company HawkCell to democratise MRI imaging

11th March 2024

Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024isease transgenic model to be presented at AD/PD™ 2024 Conference

8th March 2024

Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023

6th March 2024

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic

5th March 2024